Clinical Research Detail Title Of Study Sero-surveillance to assess rubella susceptibility including assessment of immunogenicity and safety of Rubella vaccine in females aged 18-24 years. Disease Condition To estimate proportion of girl students susceptible to Rubella and provide them vaccination and also determine post-vaccination protective immune response. Phase of Trial Phase-4 Discipline Immunology Start date of Trial 2/8/2011 Closing Date of Trial 2/8/2012 If you are a doctor interested in clinical research then upload your profile. Click here If you are a hospital interested in clinical research then upload your profile. Click here If you are a patient interested to know more about this clinical trial mail us at:   [email protected]